The responses of streptozotocin (STZ)-induced diabetic rats for the aqueous Chrozophora tinctoria (L.) Rafin leaves extracts were studied in this new work. To achieve this aim, Physiological, biochemical and histological parameters of (STZ) diabetic rats are evaluated.
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Animal Models
The male rats were purchased from Biotechnology Research Center of AL-Nahrain University, Iraq. The rats have 90 days of age and 220 ± 10 g of weight. The rats maintained in a 12 h for both light and dark cycles at 27°C during the study in the animal house. The roles of National Institutes of Health policy were followed for animal care during the experiment. Control and treated rats were received food and water ad libitum.
Diabetic Model rats and treatment
The male rats intraperitoneally injected by a single dose of 55 mg/kg BW STZ (Sigma-Aldrich) that dissolved in saline solution [20] . The normal control group of rats received an equivalent amount of saline solution. After two days of injection and by (using the glucometerACCU-Check, Roche Diagnostics Corporation, USA), the levels of fasting blood glucose were checked. The rats were considered diabetic with fasting blood glucose over 11mmol/L [21] .
Extract Chrozophora tinctoria (L.) Rafin solution was administrated with different selected doses as daily drink. The doses were daily prepared in order to avoid oxidation and rancidity and unconsumed food over 24 h. Animals used as normal control received standard rat pellet with ad libitum, distilled water till the end of the experiment.
Animals Experimental Design
Twenty-five male rats were randomly divided into five groups and placed in cages according to the groups, containing 5 rats per group. Group I, considered as the normal control, given standard food and water for a period of 35 days; Group II, served as the diabetic control, given Streptozotocin 55mg/kg b.w. as a single dose; Group III, received Streptozotocin (55mg/kg b.w.) and given leaves aqueous extract of Chrozophora tinctoria (L.) Rafin 50mg/kg b.w. administrated orally every day for a period of 35days); Group IV, received Streptozotocin (55mg/kg b.w.) and given leaves aqueous extract of Chrozophora tinctoria (L.) Rafin 70mg/kg b.w. administrated orally every day for a period of 35 days. Group V received Streptozotocin (55mg/kg b.w.) and given leaves aqueous extract of Chrozophora tinctoria (L.) Rafin 90mg/kg b.w administrated orally every day for a period of 35 followed by receiving standard food and water for diabetic control and the treated diabetic rats. After 35days, the rats were fasted for 12-hours and sacrificed by inhalation mild diethyl ether. Blood samples were obtained by means of heart puncture, plasma was separated and stored for glucose, insulin and liver enzymes determination, liver tissues were collected for histological study.
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AJBM 2019;7(1):37 -51 doi:10.18081/2333-5106/019-8/1-12 1000 mg/kg) of the extract respectively. The selected doses never showed physical signs of toxicity, or body weight changes up to 14 days. No death in animals was observed up to 950 mg/kg of aqueous Chrozophora tinctoria (L.) Rafin extract. So, 50, 70 and 90 mg/kg doses of body weight were selected as effective doses for medication experiments [22] .
Estimation of glucose, insulin, ATP, AST and ALP
The blood glucose was estimated using a glucose enzymatic-colorimetric test kit (Glucose-TR. SPAIN). Insulin levels were determined by using (ELISA) kit (Accu Bind-Elisa -microwells-USA) according to the instructions. Determination of selected Liver enzymes, Alanine aminotransferase ALT, Aspartate transferase AST, and Alkaline phosphatase ALP tests were estimated using BIO RAD ( LiquiCHEKTM)kit -USA.
Tissue Collection and Histopathology
At the end of the experiment, the tissue sections were excised from rats livers according to [23, 24] . The livers were fixed in 10% buffered formalin solution. After that, the tissue samples were embedded in paraffin block wax for histological study. Sections of 4-6 μm thickness were taken using rotary microtome (Lecia), stained with hematoxylin and eosin (H&E) [25] . The stained slides were then examined with APCAM-5 USB 2 digital cameras attached to a computer monitor.
Statistical analysis
The data were presented using one-way ANOVA and Newman-Keuls Multiple Comparison Test, N=5, NS (NON-SIGNIFICANT) *P<0.05, **P<0.01, and ***P<0.001.
Results

Body Weight and Blood Glucose Levels
As shown in Figure 1 (a) the administration of Chrozophora tinctoria (L.) Rafin aqueous extract cause slightly changes on body weight in diabetic control and all the treated groups. A significant loss of body weight in the diabetic control group rats was observed when compared to control healthy group. In addition, there was a significant gain of body weight in the treated groups. The maximum gain was at dose of 90 mg/kg. Figure 1 The liver sections obtained from STZ-diabetic rats treated with different doses of Chrozophora tinctoria (L.) Rafin (50 mg/kg, 70 mg/kg and 90 mg/kg) showed less pathological changes and improved liver hepatocytes. In ( Figure 6 ) the tissue section of liver after treated with extract of 50 mg/kg showed the hepatocytes have prominent nuclei, reduced fatty degenerations in some locations of liver parenchyma. The portal area was irregular in shape with some cluster of inflammatory cells near portal area and the hepatocytes arrangement as short hepatic cords, surrounded by some of kupffer cells. The tissue section of liver after treated with extract 70 mg/kg showed in (Figure 7) . Normal liver parenchyma without fatty degeneration was observed, the portal area was normal structure with prominent bile duct. Histological results noted disappeared of the clusters of inflammatory cells, the most hepatocytes arrangement as long hepatic cords. The central vein was normal in shape and lumen but reduced in blood flow so, the hepatic artery has prominent lumen without blood. Current results showed prominent bile duct through the liver parenchyma. Tissue section of liver after treated with extract 90mg/kg is given in (Figure 8 ). The liver showed normal arrangement of hepatic cords, which consist of normal hepatocytes. The hepatocytes have clear nuclei with normal cytoplasm. The tissue section of liver showed completely the absence of inflammatory cells, no fatty degeneration, generally the liver parenchyma have very long hepatic cords with normal distribution of kupffer cells between hepatic cords. The portal area was normal in shape. The bile duct appeared filled with secretion. The central veins have blood cells compared with previous groups. Current result of liver showed normal spaces between the hepatic cords. The tissue results of liver after treated with 90mg/kg were similar to tissue structure of control group generally. Highest improvement as well as hepatoprotective effect exhibited in the dose of 90 mg/kg as mention in (Figure 7) , as compared to the control group in (Figure 4 ). 
Insulin Levels and Liver Enzymes
Discussion
In order to investigate the toxicological effect of the Chrozophora tinctoria (L.) Rafin extract prior to their oral administration in adult rats, different concentrations of the aqueous extract were tested. The aqueous extract had no any toxic effect in the general behavior, no death was recorded when given at the dose (50 to 900mg/kg). However, there was a dose-involved presents signs of toxicity and mortality at the higher concentrations. These results could be explained safety nature of the plant extract on rats as mention in (Figure 3) . Body weight is one of the factors related to metabolic regulation for diabetes. STZ diabetic rats showed body weight loss might occurred due to increasing in muscle wasting [26] or might be due to loss of tissue proteins [27] . In this direction, the reduced level of glucose is compensated by stimulating gluconeogenesis in cells, which causes a decrease in the body weight, as well as insulin deficiency inhibits all anabolic processes and promotes catabolic processes, generally leading further to body weight loss, through increase of glycosuria and polyuria [28] . However, body weight decreased of STZ diabetic rats might be due to a toxic effect of STZ. Treatment with Chrozophora tinctoria (L.) Rafin extract improved the reduction in body weight in diabetic rats, and maintained food and water intake. In (Figure 1 (a) ) the administration of aqueous extract Chrozophora tinctoria (L.) Rafin to experimental diabetic rats showed improvement in body weight when compared to the non-treated group, which may be due to the protection effect of the extract or due to the bioactive constituents of Chrozophora tinctoria (L.) Rafin to maintain hyperglycemia. Administration of Chrozophora tinctoria (L.) Rafin to STZ-induced diabetic rats after 35 days showed a decrease of the plasma glucose level (see Figure 1 (b) ), perhaps by the augmenting quantity of insulin in all treated diabetic rats. Additionally, the mechanism of action of aqueous Chrozophora tinctoria (L.) Rafin extract is unknown, involved in utilization of glucose and regulate insulin secretion. Plasma insulin levels in STZ diabetic rats were observed decreased significantly. Whereas treated of diabetic rats with Chrozophora tinctoria (L.) Rafin extract shows increases in plasma insulin level (Figure 2 (a) ). Common biochemical markers to determine changes in liver function namely ALT, AST and ALP were also quantified. All these enzymes levels increase in activity during diabetes which indicates liver dysfunction [29] . The Figures (4, 5, 6, 7) , liver section of STZ induced diabetic rats showed several liver alterations due to the lack of insulin. The major alteration including fatty degenerations in different locations of liver parenchyma, abnormal hepatic cords with wide cystic dilation and aggregation of inflammatory cells. The livers of the control untreated diabetic rats showed some of hepatocytes lost their nuclei, and others have clear cytoplasmic vacuoles.
The tissue section showed abnormal portal area with prominent spaces between abnormal hepatocytes, similar to other experimentally induced diabetic animal models [30, 31] . This damage is partially reversed by the Chrozophora tinctoria (L.) Rafin extract treatment. The liver tissue of the control group (Figure 4 ) did not show any histological alteration the section presented typical histological organization, normal portal areas in agreement with the description of [32] . In diabetic rats treated with Chrozophora tinctoria (L.) Rafin extract. The major changes detected in diabetic livers were hydropic swelling, disarrangement in hepatocytes, microvesicular vacuolization, granular degeneration, and necrotic cells [33] . Most of the plant extract significantly decreased the hepatic damages. The noted hepatocytes fatty degeneration might occur due to insulin deficiency and the mitochondrial abnormalities. Major metabolic diseases such as DM and atherosclerosis are inflammatory states, and the responses to these conditions are mediated by macrophages like Kupffer cells [34] which noted clearly in diabetic groups treated with aqueous Chrozophora tinctoria (L.) Rafin extract. Kupffer cells are mobile macrophages, adhering to the endothelial lining and located at periportal sinusoid. Kupffer cells are activated in response to over nutrition, whether a high-fat diet or a high-sucrose diet, which resulted in the fast development of hepatic insulin insensitivity leading to disorders in lipid metabolism. Kupffer cells execute two roles: either as a mediator of damage or as a protector during the regeneration and repair processes [35] . The hepatic histological observations here showed that the severities of injuries in the treated rats when compared to DC rats were maintained probably due to the presence of kupffer cells. There was no difference between liver section of treated group(90mg/kg) and the healthy group. Further, histopathological and toxicological studies are necessary in order to indicate the ability of Chrozophora tinctoria (L.) Rafin as hepatoprotactant. In the present study, histopathological findings also aid the protective potential of Chrozophora tinctoria (L.) Rafin aqueous extract to stimulate the activity of insulin secretion during treated diabetes.
Conclusions
The aim of current study was to evaluate the antidiabetic potential and hepatoprotective effect However, further studies on main components are necessary to find out the responsible mechanism of action of this plant extract in ameliorating diabetic hepaotopathy.
